Global Laboratory Reagents Industry New York, Sept. 04,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
142
Global Laboratory Reagents Industry

New York, Sept. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Laboratory Reagents Industry" - https://www.reportlinker.com/p05485931/?utm_source=GNW 5 Billion by 2027, growing at a CAGR of 5% over the analysis period 2020-2027. Molecular Biology, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$13.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biochemistry (IVD) segment is readjusted to a revised 3.4% CAGR for the next 7-year period. The U.S. Market is Estimated at $5.6 Billion, While China is Forecast to Grow at 4.6% CAGR The Laboratory Reagents market in the U.S. is estimated at US$5.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR. Cell/Tissue Culture Segment to Record 4.7% CAGR In the global Cell/Tissue Culture segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.3 Billion in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3 Billion by the year 2027.We bring years of research experience to this 17th edition of our report. The 259-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others,

  • A.G. Scientific Inc.
  • Abbott Diagnostics
  • Agilent Technologies, Inc.
  • BD Biosciences
  • Beckman Coulter Inc.
  • bioMérieux
  • Bio-Rad Laboratories Inc.
  • Exalpha Biologicals Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Lonza Biologics Ltd.
  • Merck KGaA
  • Meridian Life Science Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen N.V.
  • R&D Systems
  • SDIX LLC
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Thermo Fischer Scientific Inc.
  • Waters Corp

Read the full report: https://www.reportlinker.com/p05485931/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Laboratory Reagents: An Introductory Prelude Recent Market Activity Growing Life Sciences R&D and Healthcare Spending Creates Conducive Environment for Laboratory Reagents Upward Trajectory in Med Tech Sector Generates Parallel Opportunities Developed Regions to Remain as Major Revenue Contributors Developing Regions: Hotspots for Future Growth Stable Economic Scenario to Keep Market Sentiment Intact in the Near Term Global Competitor Market Shares Laboratory Reagents Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS A.G. Scientific, Inc. (USA) Abbott Diagnostics (USA) Agilent Technologies, Inc. (USA) BD Biosciences (USA) Beckman Coulter, Inc. (USA) bioMérieux (France) Bio-Rad Laboratories, Inc. (USA) Exalpha Biologicals, Inc. (USA) F. Hoffmann-La Roche Ltd. (Switzerland) FUJIFILM Wako Pure Chemical Corporation (Japan) GE Healthcare (UK) Lonza Biologics Ltd. (Switzerland) Merck KGaA (Germany) Meridian Life Science, Inc. (USA) PerkinElmer, Inc. (USA) Promega Corporation (USA) Qiagen N.V. (Netherlands) R&D Systems (USA) SDIX, LLC (USA) Shimadzu Corporation (Japan) Takara Bio, Inc. (Japan) Thermo Fisher Scientific Inc. (USA) Waters Corp. (USA) 3. MARKET TRENDS & DRIVERS Growing Prevalence of Infectious & Chronic Diseases Pushes Demand for Laboratory Reagents Emphasis on Advanced Disease Diagnosis Methods Underpins Volume Growth Expanding Role of Contract Manufacturing Bodes Well for Market Growth Reagents Assume Critical Importance in Molecular Biology Processes Antibodies: Therapies of Future PCR Reagents Benefit from Growing Popularity of PCR Technologies Uptrend in Gene Expression Analysis Steers Momentum for Gene Expression Reagents Next-Generation Sequencing Technologies Steer Demand for Highly Pure Reagents Expanding Use Case for Cytokine & Chemokine Immunoassay Reagents Increased Opportunities for Carbohydrate Analysis Reagents Growing Use of Immunohistochemistry Creates High-Potential Opportunities Concerns over Environmental Issues Spur Demand for Environmental Testing Reagents Cell Culture and Tissue Culture: A Key Area for Laboratory Reagents Factors Fuelling Demand for Cell Culture and Tissue Culture Reagents Chromatography Reagents Demonstrate Steady Growth Electrophoresis Reagents Set to Make Bigger Gains Separation & Purification Products: Important in Academic & Industrial Research Reagents Market Gears Up for PoC Tests Liquid-Stable Reagent Formulations Gain Prominence Complex Reagents Seek Opportunities in Multiplex Assays Market Sees Significant Shift in Demand Patterns 4. GLOBAL MARKET PERSPECTIVE Table 1: Laboratory Reagents Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Laboratory Reagents Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 Table 3: Laboratory Reagents Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Molecular Biology (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 Table 5: Molecular Biology (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 6: Molecular Biology (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Biochemistry (IVD) (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027 Table 8: Biochemistry (IVD) (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019 Table 9: Biochemistry (IVD) (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027 Table 10: Cell/Tissue Culture (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027 Table 11: Cell/Tissue Culture (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019 Table 12: Cell/Tissue Culture (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 Table 13: Carbohydrate Analysis (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 Table 14: Carbohydrate Analysis (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 15: Carbohydrate Analysis (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 Table 16: Cytokine & Chemokine Testing (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 Table 17: Cytokine & Chemokine Testing (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 Table 18: Cytokine & Chemokine Testing (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 19: Immunohistochemistry (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 Table 20: Immunohistochemistry (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 Table 21: Immunohistochemistry (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 Table 22: Environmental Testing (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 Table 23: Environmental Testing (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 24: Environmental Testing (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Laboratory Reagents Market Share (in %) by Company: 2018 & 2025 Market Analytics Table 25: United States Laboratory Reagents Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 26: Laboratory Reagents Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 Table 27: Laboratory Reagents Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 CANADA Table 28: Canadian Laboratory Reagents Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 29: Laboratory Reagents Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 30: Canadian Laboratory Reagents Market Share Analysis by Application: 2012 VS 2020 VS 2027 JAPAN Table 31: Japanese Demand Estimates and Forecasts for Laboratory Reagents in US$ Million by Application: 2020 to 2027 Table 32: Japanese Laboratory Reagents Market in US$ Million by Application: 2012-2019 Table 33: Laboratory Reagents Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 CHINA Table 34: Chinese Demand for Laboratory Reagents in US$ Million by Application: 2020 to 2027 Table 35: Laboratory Reagents Market Review in China in US$ Million by Application: 2012-2019 Table 36: Chinese Laboratory Reagents Market Share Breakdown by Application: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European Laboratory Reagents Market: Competitor Market Share Scenario (in %) for 2018 & 2025 Market Analytics Table 37: European Laboratory Reagents Market Demand Scenario in US$ Million by Region/Country: 2020-2027 Table 38: Laboratory Reagents Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 Table 39: European Laboratory Reagents Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 40: European Laboratory Reagents Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 41: Laboratory Reagents Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 42: European Laboratory Reagents Market Share Analysis by Application: 2012 VS 2020 VS 2027 FRANCE Table 43: Laboratory Reagents Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 Table 44: French Laboratory Reagents Historic Market Review in US$ Million by Application: 2012-2019 Table 45: French Laboratory Reagents Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 GERMANY Table 46: Laboratory Reagents Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 47: German Laboratory Reagents Market in Retrospect in US$ Million by Application: 2012-2019 Table 48: Laboratory Reagents Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 ITALY Table 49: Italian Demand for Laboratory Reagents in US$ Million by Application: 2020 to 2027 Table 50: Laboratory Reagents Market Review in Italy in US$ Million by Application: 2012-2019 Table 51: Italian Laboratory Reagents Market Share Breakdown by Application: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 52: United Kingdom Demand Estimates and Forecasts for Laboratory Reagents in US$ Million by Application: 2020 to 2027 Table 53: United Kingdom Laboratory Reagents Market in US$ Million by Application: 2012-2019 Table 54: Laboratory Reagents Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 REST OF EUROPE Table 55: Rest of Europe Laboratory Reagents Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 56: Laboratory Reagents Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 57: Rest of Europe Laboratory Reagents Market Share Analysis by Application: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 58: Laboratory Reagents Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 Table 59: Asia-Pacific Laboratory Reagents Historic Market Review in US$ Million by Application: 2012-2019 Table 60: Asia-Pacific Laboratory Reagents Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 REST OF WORLD Table 61: Rest of World Laboratory Reagents Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 62: Laboratory Reagents Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 63: Rest of World Laboratory Reagents Market Share Analysis by Application: 2012 VS 2020 VS 2027 IV. COMPETITION Total Companies Profiled: 160 Read the full report: https://www.reportlinker.com/p05485931/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CACI Hits $50K Milestone in Service Dog Program

Updated Category News Views 13

Ice Blocking for a Noble Cause Last I checked, mixing the adrenaline of ice hockey with the grit of veteran support isn't your typical skate on thin ice. But CACI International Inc (NYSE:CACI), with their Good Dogs for Great Americans program, is doing just that. They're taking every blocked shot by the Washington Capitals and turning it into a stepping stone for veterans...

Continue Reading
Jacquie Lawson's Advent Calendar Delights Fans for 17th Year

Updated Category News Views 63

A Festive Tradition with a Twist The Jacquie Lawson Advent calendar is back for its 17th season, and it's no ho-hum affair. This time, the scene is set against the breathtaking backdrop of England's Lake District. If you've been yearning for a bit of that classic literary and natural charm, this is your ticket—minus the airfare. The calendar isn't just a countdown; it's...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 87

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
OCI Cleared to Merge with Orascom, Sets Delisting Date

Updated Category News Views 117

OCI N.V. has hit a milestone. The shareholders have given the green light to merge with Orascom Construction PLC. This move is fleshed out with an updated roadmap that sharp-eyed investors need to watch closely. The company's shares will no longer be trading on Euronext Amsterdam by late November 2026, contingent on regulatory nods and other variables swirling in the...

Continue Reading
Sentral Expands: Fort Lauderdale & San Diego Additions

Updated Category News Views 112

Sentral's Strategic Leap into New Markets Ever heard of a company spreading its wings like wildfire? That’s Sentral for you, crashing into Fort Lauderdale and pushing deeper roots in San Diego. We’re not talking minor plays here—these two fresh additions make Sentral a resident-giant stretched across 22 markets. Seems like they’re on a mission to ink their mark...

Continue Reading
Lecanemab's New Data: What Investors Should Monitor

Updated Category News Views 35

Lecanemab: A Bold Step in Alzheimer's Treatment? Investors eyeing the biotech sector should pay close attention to the upcoming CTAD conference in 2026, where BioArctic AB's partner, Eisai, is set to present fresh data on lecanemab (Leqembi®). This isn't just another pharma front-page story—this is about potential breakthroughs in Alzheimer's treatment that's caught...

Continue Reading
WhiteFiber's Q3 2026 Call: Key Insights Await Investors

Updated Category News Views 51

Eyes on WhiteFiber's Upcoming Earnings Call You know the drill—results call season can make or break some days for us investors. WhiteFiber, Inc. (NASDAQ: WYFI) is gearing up for their third-quarter earnings call on November 10, 2026, at 9:00 a.m. Eastern Time. As a player in the AI infrastructure game, expectations ride high. With their networks and data centers...

Continue Reading
Kansas City Life's Q3: Earnings Dip, but Growth Ahead

Updated Category News Views 0

Striking a Balance: Kansas City Life's Q3 They say numbers don’t lie, and Kansas City Life Insurance just shared their latest. This quarter, things weren't all smooth sailing, but there's a silver lining. For Q3 2026, net income clocked in at $1.7 million, or $0.18 per share, down from last year’s $2.8 million, or $0.29 per share. Sure, it wasn't all sunshine and...

Continue Reading
Shareholder Stakes at Risk in Major Mergers

Updated Category News Views 15

Deals in the Spotlight: What's at Stake? Ever wonder if you're getting the short end of the stick while company insiders walk away with the spoils? That's the song and dance investors face with the likes of ADT Inc., Instacart, and MidCap Financial Investment Corporation lately. If you're wearing the shareholder hat, you might want to tune into the noise around these...

Continue Reading
Hehe Culture's Timeless Wisdom Explored at Forum

Updated Category News Views 39

Hehe Forum: Bridging the Past and Present Sometimes, the past isn't just anchor weight, it's a compass guiding us through the murky waters of today. The Hehe Culture Forum's latest gathering in Tiantai County, Zhejiang Province, aimed to unravel just how much ancient wisdom can still steer the course in this fast-changing world. Delegates from 23 nations joined forces,...

Continue Reading

Top 5 Most Recently Viewed Articles

Chart Industries Transitions to New Leadership in Upcoming Merger

Updated Category News Views 242

Chart Industries Announces Leadership Change Chart Industries (NYSE: GTLS) is taking significant steps toward a future transition as CEO Jill Evanko has announced plans to assume a senior advisor role starting in early 2026. This change comes as she prepares to take on a new executive opportunity within a privately owned company. Evanko has been essential in steering the...

Continue Reading
Cornish Metals Expands South Crofty Tin Project Operations

Updated Category News Views 287

Cornish Metals Expands Land Financing at South Crofty Tin Project Cornish Metals Inc. (AIM/TSX-V: CUSN), a dedicated mineral exploration and development company, proudly reports an increase in its land ownership at the South Crofty tin project. This significant acquisition involves approximately 4.5 acres from Cornwall Council, enhancing direct access to the vital...

Continue Reading
Pacific Nations Cup 2025 Set for Exciting Semi-Finals in Denver

Updated Category News Views 663

Exciting Semi-Finals of the Pacific Nations Cup 2025 World Rugby has unveiled the schedule for the much-anticipated Pacific Nations Cup 2025 (PNC). This prestigious tournament will unfold against the backdrop of the iconic DICK'S Sporting Goods Park, bringing together six elite teams for a day filled with high-stakes rugby action. Host City: Denver Denver will serve as...

Continue Reading
Record-Breaking Achievements by AskGamblers Complaint Service

Updated Category News Views 127

Remarkable Achievement of AskGamblers Casino Complaint Service AskGamblers Casino Complaint Service (AGCCS) has reached an impressive milestone, successfully resolving complaints and returning over $80 million to players globally. This dedicated service is a vital part of AskGamblers, which is committed to ensuring fair treatment for online casino users. Recent Success in...

Continue Reading
Important Update for Treace Medical Investors: Join Action

Updated Category News Views 384

Join the Class Action Suit Against Treace Medical Concepts Attention to all shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI): an essential opportunity to register for a class action lawsuit is now open. This announcement from The Gross Law Firm urges you to take action if you purchased shares of TMCI during the designated class period. Why You Should Consider...

Continue Reading